Pneumatic Tissue Expander Facilitates Breast Reconstruction
|
By HospiMedica International staff writers Posted on 04 Jan 2017 |
|
Image: A pneumatic system uses compressed CO2 to expand breast tissue (Photo courtesy of AirXpanders).
An innovative wireless tissue expander system provides a needle-free alternative to saline breast expanders for women undergoing breast reconstruction.
The AeroForm system includes a tissue expander placed underneath the chest muscle following a mastectomy, and a wireless controller. The device uses compressed carbon dioxide (CO₂) gas within an internal reservoir to fill the expander using the hand-held, wireless dose controller. Patients and physicians can release 10cc of CO2, up to three times per day to gradually inflate the expander, stretching the tissue to prepare for a breast implant. This can be done from any location, such as home or work, and only takes a few seconds.
Use of the system greatly reduces the time needed to reach a fully expanded state, when compared to expansion via saline injection administered by a doctor, and also offers a needle-free alternative to the multiple painful saline injections that could be a barrier to reconstructive surgery for some patients. The system also reduces the time patients need to spend traveling to and waiting at their surgeon’s office. The AeroForm system is a product of AirXpanders (Palo Alto, CA, USA), and has been approved by the U.S. Food and Drug Administration (FDA).
“While AeroForm doses are a small 10cc puff each, they add up over time and can get a patient fully expanded within 17 days. A saline device can take upward of three months to reach the same state,” said Scott Dodson, CEO of AirXpanders. “As U.S. mastectomy rates continue to rise and growing numbers of women undergo breast reconstruction, we are confident AeroForm will positively redefine the reconstruction process for women in the U.S.”
“Reconstruction is one of the last phases of a long and sometimes taxing journey for women who are treated for breast cancer,” said Professor Jeffrey Ascherman, MD, of Columbia University Medical Center (CUMC; New York, NY, USA). “They have lost time and control, and are eager to get back to their lives. Needle-free, patient-guided expansion could be a suitable option for many women undergoing the reconstruction process.”
Related Links:
AirXpanders
Columbia University Medical Center
The AeroForm system includes a tissue expander placed underneath the chest muscle following a mastectomy, and a wireless controller. The device uses compressed carbon dioxide (CO₂) gas within an internal reservoir to fill the expander using the hand-held, wireless dose controller. Patients and physicians can release 10cc of CO2, up to three times per day to gradually inflate the expander, stretching the tissue to prepare for a breast implant. This can be done from any location, such as home or work, and only takes a few seconds.
Use of the system greatly reduces the time needed to reach a fully expanded state, when compared to expansion via saline injection administered by a doctor, and also offers a needle-free alternative to the multiple painful saline injections that could be a barrier to reconstructive surgery for some patients. The system also reduces the time patients need to spend traveling to and waiting at their surgeon’s office. The AeroForm system is a product of AirXpanders (Palo Alto, CA, USA), and has been approved by the U.S. Food and Drug Administration (FDA).
“While AeroForm doses are a small 10cc puff each, they add up over time and can get a patient fully expanded within 17 days. A saline device can take upward of three months to reach the same state,” said Scott Dodson, CEO of AirXpanders. “As U.S. mastectomy rates continue to rise and growing numbers of women undergo breast reconstruction, we are confident AeroForm will positively redefine the reconstruction process for women in the U.S.”
“Reconstruction is one of the last phases of a long and sometimes taxing journey for women who are treated for breast cancer,” said Professor Jeffrey Ascherman, MD, of Columbia University Medical Center (CUMC; New York, NY, USA). “They have lost time and control, and are eager to get back to their lives. Needle-free, patient-guided expansion could be a suitable option for many women undergoing the reconstruction process.”
Related Links:
AirXpanders
Columbia University Medical Center
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
Desk Aneroid Sphyg
Diagnostix 750D+
Latest Surgical Techniques News
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
- Skull Implant Design Could Shape Surgical Outcomes
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Critical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
